Strom Brian L, Schinnar Rita, Apter Andrea J, Margolis David J, Lautenbach Ebbing, Hennessy Sean, Bilker Warren B, Pettitt Dan
Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6021, USA.
N Engl J Med. 2003 Oct 23;349(17):1628-35. doi: 10.1056/NEJMoa022963.
The safety of sulfonamide nonantibiotics is unclear in patients with prior allergic reactions to sulfonamide antibiotics.
We conducted a retrospective cohort study using the General Practice Research Database in the United Kingdom, examining the risk of allergic reactions within 30 days after the receipt of a sulfonamide nonantibiotic. Patients with evidence of prior hypersensitivity after the receipt of a sulfonamide antibiotic were compared with those without such evidence. Similar analyses were also performed with the use of penicillins instead of sulfonamides, to determine whether any risk was specific to sulfonamide cross-reactivity.
Of 969 patients with an allergic reaction after a sulfonamide antibiotic, 96 (9.9 percent) had an allergic reaction after subsequently receiving a sulfonamide nonantibiotic. Of 19,257 who had no allergic reaction after a sulfonamide antibiotic, 315 (1.6 percent) had an allergic reaction after receiving a sulfonamide nonantibiotic (adjusted odds ratio, 2.8; 95 percent confidence interval, 2.1 to 3.7). However, the risk of allergic reactions was even greater after the receipt of a penicillin among patients with a prior hypersensitivity reaction to a sulfonamide antibiotic, as compared with patients with no such history (adjusted odds ratio, 3.9; 95 percent confidence interval, 3.5 to 4.3). Furthermore, among those with a prior hypersensitivity reaction after the receipt of a sulfonamide antibiotic, the risk of an allergic reaction after the subsequent receipt of a sulfonamide nonantibiotic was lower than the risk of an allergic reaction after the subsequent receipt of a penicillin (adjusted odds ratio, 0.7; 95 percent confidence interval, 0.5 to 0.9). Finally, the risk of an allergic reaction after the receipt of a sulfonamide nonantibiotic was lower among patients with a history of hypersensitivity to sulfonamide antibiotics than among patients with a history of hypersensitivity to penicillins (adjusted odds ratio, 0.6; 95 percent confidence interval, 0.5 to 0.8).
There is an association between hypersensitivity after the receipt of sulfonamide antibiotics and a subsequent allergic reaction after the receipt of a sulfonamide nonantibiotic, but this association appears to be due to a predisposition to allergic reactions rather than to cross-reactivity with sulfonamide-based drugs.
对于既往对磺胺类抗生素有过敏反应的患者,磺胺类非抗生素药物的安全性尚不清楚。
我们利用英国全科医疗研究数据库进行了一项回顾性队列研究,调查服用磺胺类非抗生素药物后30天内发生过敏反应的风险。将既往服用磺胺类抗生素后有超敏反应证据的患者与无此类证据的患者进行比较。还使用青霉素替代磺胺类药物进行了类似分析,以确定是否存在任何特定于磺胺类交叉反应的风险。
在969例服用磺胺类抗生素后发生过敏反应的患者中,96例(9.9%)在随后服用磺胺类非抗生素药物后发生了过敏反应。在19257例服用磺胺类抗生素后未发生过敏反应的患者中,315例(1.6%)在服用磺胺类非抗生素药物后发生了过敏反应(校正比值比为2.8;95%置信区间为2.1至3.7)。然而,与无此类病史的患者相比,既往对磺胺类抗生素有超敏反应的患者在服用青霉素后发生过敏反应的风险甚至更高(校正比值比为3.9;95%置信区间为3.5至4.3)。此外,在既往服用磺胺类抗生素后有超敏反应的患者中,随后服用磺胺类非抗生素药物后发生过敏反应的风险低于随后服用青霉素后发生过敏反应的风险(校正比值比为0.7;95%置信区间为0.5至0.9)。最后,有磺胺类抗生素过敏史的患者在服用磺胺类非抗生素药物后发生过敏反应的风险低于有青霉素过敏史的患者(校正比值比为0.6;95%置信区间为0.5至0.8)。
服用磺胺类抗生素后的超敏反应与随后服用磺胺类非抗生素药物后的过敏反应之间存在关联,但这种关联似乎是由于过敏反应的易感性,而非与磺胺类药物的交叉反应。